Kess Pharmaceuticals Limited

What Kess Pharmaceuticals Limited does

Kess Pharmaceuticals Limited is a Ghana-headquartered pharmaceutical entity incorporated in 2018 and operated out of Accra. According to the available firmographic record, the company is privately held, has no parent organization, no subsidiaries, and operates with a micro-team of 1–10 employees. The corporate name suggests involvement in the pharmaceutical value chain — likely distribution, importation, or retail of medicinal products within the Ghanaian market — though no specific therapeutic categories, dosage forms, or product lines are disclosed in the source material.

The firm has no recorded funding rounds, no disclosed investors, no mergers or acquisitions, no leadership team roster, and no public-facing corporate communications beyond a domain (kesspharma.com) that, at the time of aggregation, presented only a verification/loading page with no substantive product, pricing, or service content. No regulatory certifications, partnerships, awards, patents, or compliance accreditations are recorded.

Commercial mechanics are similarly undisclosed: no revenue model, pricing structure, distribution channels, customer segments, or named customer relationships appear in the source data. Operational status, operating geographies beyond the Ghana headquarters, social-media presence, and management composition are all unverifiable from the supplied material, leaving Kess Pharmaceuticals Limited as a thinly documented corporate entity whose actual scope of activity, customer base, and revenue scale cannot be reliably triangulated from the available evidence.

Name

Kess Pharmaceuticals Limited

Legal name

Kess Pharmaceuticals Limited

Website

https://kesspharma.com

Company type

Private

Founded year

2018

Headcount range

1–10 employees

Short description

Kess Pharmaceuticals Limited is a privately held Ghana-based pharmaceutical entity, founded in 2018 and headquartered in Accra, operating with a 1–10 employee micro-team. The firm has no disclosed product lines, customer base, revenue stream, or partnerships in the available source data.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Medicinal products
• Drug distribution
• Pharmaceutical retail

Headquarters

HQ city

Accra

HQ country

Ghana

HQ region

Africa

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Others

Core offering

Kess Pharmaceuticals Limited is a Ghana-based pharmaceutical company (founded 2018, 1–10 employees, headquartered in Accra) whose name indicates it operates in the manufacture, distribution, and/or retail of pharmaceutical products. The company's public website currently displays only a verification/loading page, so specific product lines, therapeutic areas, and customer segments cannot be confirmed from available source material.

Product overview

No product or service information available. The website (http://kesspharma.com/) displayed only a verification/loading page with no accessible content.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Ernest Chemists Limited: Ghanaian pharmaceutical manufacturer with a broad generics portfolio. Comparable to Kess as a domestic Ghanaian pharma producer serving the same local market and regulatory framework.
• Kinapharma Limited: One of Ghana's largest local pharmaceutical manufacturers and distributors. Comparable as a Ghana-based pharma company operating in branded generics and primary-care medicines across the same regulatory and competitive environment.
• Letap Pharmaceuticals Limited: West African pharmaceutical manufacturer producing generics and OTC products. Comparable to Kess as a regionally based pharma manufacturer targeting similar therapeutic categories and customer channels.
• Blueline Pharmaceuticals: Ghanaian pharmaceutical company engaged in manufacturing and distribution of generic medicines. Comparable as a local Ghana pharma player operating in the same regulatory and distribution landscape.

Broad incumbents

• Cipla Limited: Major global generic and respiratory pharmaceutical company with strong distribution into African markets. Comparable as a broad incumbent supplying branded generics and respiratory/primary-care products across Ghana.
• Aurobindo Pharma: Large global generic pharmaceutical manufacturer with active presence in African markets including Ghana. Comparable as a competing generic-drug manufacturer whose products Kess would compete with on local shelves and tenders.

Regional players

• Dansol Pharmaceuticals: Pharmaceutical company with operations in West Africa. Comparable to Kess as a regional pharma manufacturer addressing similar disease burdens and primary-care therapeutic categories.

Market position

Strengths3 records

Weaknesses3 records

Key risks5 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/kesspharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kess Pharmaceuticals Limited